These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2379515)

  • 1. Diagnostic alternatives to second look in ovarian cancer.
    Torretta L; Balestreri D; Fasola M; Schinko E; Scorbati E; Tateo S
    Eur J Gynaecol Oncol; 1990; 11(2):145-8. PubMed ID: 2379515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer].
    Meden H; Rath W; Ohlmeyer D
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer.
    Sugiyama T; Nishida T; Komai K; Nishimura H; Yakushiji M; Nishimura H
    Int J Gynaecol Obstet; 1996 Sep; 54(3):251-6. PubMed ID: 8889633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Computed tomography and tumor markers as diagnostic alternatives to second-look surgery in the treatment of malignant ovarian tumors].
    La Fianza A; Campani R; Dore R; Babilonti L; Torretta L
    Radiol Med; 1992 Apr; 83(4):374-82. PubMed ID: 1603993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The accuracy of CT and tumor markers in the detection of a recurrent ovarian carcinoma].
    Wakabayashi Y; Ishida J; Kotake F; Hirose M; Kawana K; Abe K; Amino S; Negishi Y; Akiya K
    Gan No Rinsho; 1989 Sep; 35(10):1127-31. PubMed ID: 2550684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings].
    Meden H; Rath W; Teichmann A; Kuhn W
    Onkologie; 1989 Oct; 12(5):217-20. PubMed ID: 2685687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.
    Jäger W; Adam R; Wildt L; Lang N
    Arch Gynecol Obstet; 1988; 243(2):91-9. PubMed ID: 2456743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.
    Low RN; Duggan B; Barone RM; Saleh F; Song SY
    Radiology; 2005 Jun; 235(3):918-26. PubMed ID: 15914479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing period of time between negative second-look laparotomy and ovarian carcinoma recurrence. Multicenter study in Poland.
    Markowska J; Wilkoszarska J; Emerich J; Debniak J; Popiela A; Pańszczak M; Kornafel J; Rossochacka B; Fisher Z; Goluda M; Małecki P
    Eur J Gynaecol Oncol; 2000; 21(2):164-7. PubMed ID: 10843477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of abdominopelvic computed tomography results and findings at second-look laparotomy in ovarian carcinoma patients.
    Reuter KL; Griffin T; Hunter RE
    Cancer; 1989 Mar; 63(6):1123-8. PubMed ID: 2917315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history.
    Ferrozzi F; Bova D; De Chiara F; Garlaschi G; Draghi F; Cocconi G; Bassi P
    Clin Imaging; 1998; 22(5):364-70. PubMed ID: 9755401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer.
    Prayer L; Kainz C; Kramer J; Stiglbauer R; Schurawitzki H; Baldt M; Schima W; Poelzleitner D; Reinthaller A; Koelbl H
    J Comput Assist Tomogr; 1993; 17(4):626-32. PubMed ID: 8331235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
    Fularz M; Adamiak P; Czepczyński R; Jarząbek-Bielecka G; Rewers A; Kędzia W; Ruchała M
    Nuklearmedizin; 2015; 54(4):158-62. PubMed ID: 26076719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy.
    Khoo SK; Hurst T; Webb MJ; Dickie GJ; Kearsley JH; Mackay EV
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):765-71. PubMed ID: 3477461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.
    Guo N; Peng Z
    J Ovarian Res; 2017 Mar; 10(1):14. PubMed ID: 28284216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer recurrences in patients with no macroscopic tumor at second-look laparotomy.
    Copeland LJ; Gershenson DM
    Obstet Gynecol; 1986 Dec; 68(6):873-4. PubMed ID: 3785802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
    Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
    Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 125 surveillance and second-look laparotomy in ovarian carcinoma.
    Atack DB; Nisker JA; Allen HH; Tustanoff ER; Levin L
    Am J Obstet Gynecol; 1986 Feb; 154(2):287-9. PubMed ID: 3456202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer.
    Aravantinos D; Michalas S; Papazefkos V; Christoforaki M; Stypsaneli A; Vlachos G; Athanasiadis P
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):265-70. PubMed ID: 2227069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.